Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Tooth, Impacted 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Hematologic Neoplasms 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma, Cavernous 1Ganglioneuroblastoma 1Fibrolamellar hepatocellular carcinoma 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Renal Cell 1Breast Carcinoma In Situ 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 3Biopsy 2sargramostim 1gallium Ga 68 dotatate 1dinutuximab 1Watchful Waiting 1Temozolomide 1Specimen Handling 1Observation 1Isotretinoin 1Irinotecan 1High-Energy Shock Waves 1Ga(III)-DOTATOC 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Colony-Stimulating Factors 1Carboplatin 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Ganglioneuroblastoma × Watchful Waiting × Clear all
NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Children's Oncology Group

Phase 3 Active not recruiting
621 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡